Gastrointestinal Cancer
From the Journals
ctDNA unreliable for detecting CRC recurrence after surgery
Two ctDNA tests used for this purpose are marketed in the United States.
Conference Coverage
What’s the future of microbiome therapies in C. diff, cancer?
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in...
Latest News
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
From the Journals
Registry data support lowering CRC screening age to 45
Existing research gaps on the rates of younger-onset colorectal neoplasia need to be addressed to support these recommendations.
From the Journals
Can green tea extract protect against colorectal adenomas?
Green tea extract taken over 3 years was well tolerated but had no significant effects, according to the results of a large randomized controlled...
From the Journals
Can colorectal ESD succeed in outpatient settings?
Endoscopic submucosal dissection may yet escape the inpatient setting in Asian countries and find widespread adoption in the West, too.
From the Journals
RFA has long-lasting protective effects in esophageal cancer
A 10-year report from the United Kingdom shows the benefits are durable for patients with Barrett’s esophagus.
From the Journals
AGA Clinical Practice Update: Commentary on noninvasive CRC screening
How to tailor screening based on CRC risk, and how to be sure screening is effective.
From the Journals
AGA Clinical Practice Guidelines: Systemic HCC therapy
New therapies offer plenty of options, but evidence is sparse.
From the Journals
Heavy drinking in your 20s has lasting impact on cancer risk
People generally do not expect their heavy drinking in early adulthood to affect their cancer risk many years later.
Latest News
No new safety signals reported for pembrolizumab as kidney cancer treatment
Pembrolizumab in combination with axitinib is an FDA-approved treatment for advanced renal cell carcinoma.